Cambridge Investment Research Advisors
BME icon

Cambridge Investment Research Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886K Buy
20,629
+860
+4% +$34.2K ﹤0.01% 2425
2026
Q1 		$761K Sell
19,769
-231
-1% -$9.53K ﹤0.01% 2411
2025
Q4 		$823K Sell
20,000
-3,744
-16% -$148K ﹤0.01% 2261
2025
Q3 		$884K Sell
23,744
-2,995
-11% -$109K ﹤0.01% 2142
2025
Q2 		$975K Sell
26,739
-23,915
-47% -$867K ﹤0.01% 1970
2025
Q1 		$1.96M Buy
50,654
+6,257
+14% +$248K 0.01% 1370
2024
Q4 		$1.68M Sell
44,397
-1,244
-3% -$49.7K 0.01% 1485
2024
Q3 		$1.91M Sell
45,641
-8,964
-16% -$372K 0.01% 1385
2024
Q2 		$2.23M Buy
54,605
+2,240
+4% +$89.2K 0.01% 1216
2024
Q1 		$2.17M Buy
52,365
+2,259
+5% +$94.6K 0.01% 1208
2023
Q4 		$2.03M Buy
50,106
+410
+0.8% +$15.7K 0.01% 1191
2023
Q3 		$1.95M Buy
49,696
+682
+1% +$27.2K 0.01% 1151
2023
Q2 		$1.99M Sell
49,014
-621
-1% -$25.6K 0.01% 1177
2023
Q1 		$2.08M Sell
49,635
-1,623
-3% -$68.3K 0.01% 1101
2022
Q4 		$2.23M Sell
51,258
-2,786
-5% -$118K 0.01% 1020
2022
Q3 		$2.1M Sell
54,044
-2,308
-4% -$98.3K 0.01% 999
2022
Q2 		$2.39M Sell
56,352
-466
-0.8% -$20.2K 0.01% 962
2022
Q1 		$2.59M Buy
56,818
+1,852
+3% +$82.1K 0.01% 990
2021
Q4 		$2.67M Buy
54,966
+222
+0.4% +$10.5K 0.01% 981
2021
Q3 		$2.61M Buy
54,744
+9,255
+20% +$451K 0.01% 946
2021
Q2 		$2.21M Buy
45,489
+6,181
+16% +$296K 0.01% 1054
2021
Q1 		$1.82M Buy
39,308
+860
+2% +$40.8K 0.01% 1062
2020
Q4 		$1.83M Buy
38,448
+3,443
+10% +$156K 0.01% 964
2020
Q3 		$1.5M Sell
35,005
-380
-1% -$16.3K 0.01% 960
2020
Q2 		$1.44M Buy
35,385
+3,458
+11% +$140K 0.01% 921
2020
Q1 		$1.15M Buy
31,927
+2,006
+7% +$79.9K 0.01% 903
2019
Q4 		$1.27M Buy
29,921
+4,376
+17% +$174K 0.01% 1018
2019
Q3 		$977K Buy
25,545
+1,632
+7% +$62.8K 0.01% 1084
2019
Q2 		$930K Buy
23,913
+3,218
+16% +$122K 0.01% 1053
2019
Q1 		$823K Buy
20,695
+911
+5% +$36K 0.01% 1145
2018
Q4 		$721K Buy
19,784
+291
+1% +$11.4K 0.01% 1118
2018
Q3 		$829K Buy
19,493
+6,837
+54% +$277K 0.01% 1135
2018
Q2 		$488K Buy
12,656
+4,259
+51% +$154K 0.01% 1414
2018
Q1 		$294K Buy
+8,397
New +$299K ﹤0.01% 1684
2014
Q4 		– Sell
-5,545
Closed -$213K – 1378
2014
Q3 		$213K Buy
+5,545
New +$204K 0.01% 1266

Other funds holding BME

NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
SAM
Smith Asset Management Chiefland, Florida $127M AUM 5.85% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
PFO
PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Cambridge Investment Research Advisors's BME Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its BlackRock Health Sciences Trust (BME) stake by 4.4% in Q2 2026, buying an estimated $34.2K and bringing the position to 20,629 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

Cambridge Investment Research Advisors first reported a position in BME in Q3 2014 and has held it in 35 quarters since. The position peaked at $2.67M in Q4 2021. 31 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Cambridge Investment Research Advisors held 20,629 shares of BlackRock Health Sciences Trust worth $886K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 860 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $34.2K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2425 holding.
  • Cambridge Investment Research Advisors first reported a position in BlackRock Health Sciences Trust in Q3 2014 and has held it in 35 quarters since.
  • Cambridge Investment Research Advisors's BlackRock Health Sciences Trust position peaked at $2.67M in Q4 2021.
  • 31 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.